Adar1 Capital Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 13,000 shares of RYTM stock, worth $638,300. This represents 0.1% of its overall portfolio holdings.
Number of Shares
13,000
Previous 12,400
4.84%
Holding current value
$638,300
Previous $537 Million
0.65%
% of portfolio
0.1%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
177Shares Held
68.5MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$359 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$331 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$314 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$299 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$260 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.74B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...